Well if last week was a “not good” week, I guess this week deserves the whole “sad trombones” treatment, at least as far as the contest portfolios are concerned. The Broader market, i.e. the NASDAQ Composite gave up -0.7% for the week, an improvement over the previous week’s loss of -1.2%, but the biotech indices increased the magnitude of their losses, e.g. the S&P biotech composite went from -2.6% to -4.3%. The NASDAQ biotech index moved into negative territory for YTD returns.
Of course it wasn’t universally bad news. TCON was up +73% of its original price for the week, though not enough to put its YTD performance into the top five. It closed significantly below its peak return of an additional +150% at the end of Wednesday. The activity could be at best indirecly related to their 4th quarter results, exceeding expectations, released on the previous Wednesda (March 6), or the release of the investor's call transcript on Thursday (March 7).
CRDF was in second for the week, +60%, adding to the previous week’s gain of +83%, again several weeks after their 2023 earnings meeting expectations, moving it’s YTD performance from fifth to second (+240%).
SYRE, in third with (+35%) also continued its fifth place performance of the previous week (+37%). SLDB in fourth (+32%) at least had its annual/Q4 financials announced this week, as did fifth place LIFE (+28%), although on Saturday one analyst presented the annual earnings as a disappointment.
And as a sign of the general chaos of the last few weeks, the weeks big loser, VINC, dropped -200% of its original price, though this was after the dizzying +300% gain of the previous week, so that it still maintained its position at the top of the YTD performance, +370%. VKTX, the big winner of two weeks ago slid an additional -50% for this week, slipping below CRDF into third for YTD performance (+240%).
The biotech carnage resulted in the average portfolio losing -$5.8k for the week, so it should be no surprise that only two portfolios managed a profit. The good news at the end of February had produced a fairly fat cushion so that even now the average portfolio YTD (+$20k) is significantly outpacing the NASDAQ (+$6.4k) and thirteen out of seventeen portfolios are still in the black.
KATHLEEN was the number one for the week (+$1.5k), thanks to holdings of SLDB and LXRX. BLADERUNNER only had one holding in the black for the week, but it was a 20% position in CRDF, which earned $12k, though after the losing positions their net return was +$180, putting them in second for the week and enough to keep them at the top YTD spot (+$83k), and opening up their lead over BULBAMAN to $13k. JACK HARTMANN’s week’s loss, -$970, put them in third for the week, and returned them to the top YTD portfolios in eighth place (+$17k).
Report Time Ranges
|
|
|
|
|
| From
| To
|
|
|
|
|
|
|
|
| Recent
| 3/8/2024
| 3/15/2024
|
|
|
|
|
|
|
|
| YTD
| 12/31/2023
|
|
|
|
| Index Portfolios’ Performance
|
|
|
|
| Symbol
| Recent P/L
| Recent %
| YTD P/L
|
|
|
|
|
|
|
|
| ^IXIC
| -$745.70
| -0.7%
| $6,407.29
|
|
|
|
|
|
|
|
| ^NBI
| -$2,164.77
| -2.1%
| -$111.95
|
|
|
|
|
|
|
|
| ^SPSIBI
| -$4,811.61
| -4.3%
| $6,016.56
|
|
|
|
| Share Performance
| Recent Performance
| YTD Performance
|
| Top Five
|
| Bottom Five
|
| Top Five
|
| Bottom 5
| Symbol
| P/L / Initial Price
| Symbol
| P/L / Initial Price
| Symbol
| YTD P/L / Initial Price
| Symbol
| YTD P/L/ Initial Price
| TCON
| 73.1%
| VINC
| -198.3%
| VINC
| 372.9%
| AMLX
| -78.0%
| CRDF
| 60.1%
| VKTX
| -49.5%
| CRDF
| 239.9%
| CNSP
| -71.9%
| SYRE
| 34.6%
| TNYA
| -44.0%
| VKTX
| 236.2%
| PACB
| -61.4%
| SLDB
| 31.6%
| CCCC
| -36.6%
| JSPR
| 217.9%
| NERV
| -54.6%
| LIFE
| 28.4%
| LRMR
| -33.0%
| PYXS
| 184.4%
| KZIA
| -49.1%
| Average and Median Portfolio Performance
|
| Recent P/L
|
|
|
| YTD P/L
|
|
|
| Avg.
| Median
|
|
|
| Avg
| Median
|
|
|
| -$5,779.65
| -$5,584.11
| JR_95
|
| $20,215.80
| $16,610.18
| TECHNETIUM
| Top Seven Portfolio Performances
| Top Recent Performers
| Top YTD Performers
| Contestant (Prev. Rank)
| Recent P/L
| P/L vs. ^SPSIBI
| YTD P/L (Rank)
| Contestant (Prev. Rank)
| YTD P/L
| vs. Top Portfolio
| P/L vs. ^SPSIBI
| Rec. P/L (Rank)
| 1 - KATHLEEN (6)
| $1,478.36
| $6,289.97
| $3,118.24 (12)
| 1 - BLADERUNNER (1)
| $82,900.53
| ——
| $76,883.97
| $181.25 (2)
| 2 - BLADERUNNER (1)
| $181.25
| $4,992.86
| $82,900.53 (1)
| 2 - BULBAMAN (2)
| $70,297.72
| $12,602.82
| $64,281.16
| -$6,907.26 (11)
| 3 - JACK HARTMANN (2)
| -$969.28
| $3,842.33
| $16,971.45 (8)
| 3 - ERIKOTTO (3)
| $51,055.57
| $31,844.96
| $45,039.02
| -$9,029.55 (13)
| 4 - TOMATO (7)
| -$1,320.65
| $3,490.96
| $41,179.19 (5)
| 4 - RAJU_BIJLEE (4)
| $46,891.67
| $36,008.86
| $40,875.11
| -$13,118.38 (16)
| 5 - DART LANZER (4)
| -$2,453.06
| $2,358.54
| -$1,091.92 (14)
| 5 - TOMATO (5)
| $41,179.19
| $41,721.35
| $35,162.63
| -$1,320.65 (4)
| 6 - NOTABOT (8)
| -$2,888.88
| $1,922.73
| -$3,550.93 (15)
| 6 - TRACE I11 (6)
| $22,255.86
| $60,644.67
| $16,239.30
| -$14,678.66 (17)
| 7 - ARTHUR RADLEY (13)
| -$3,815.15
| $996.46
| $4,254.14 (11)
| 7 - DEW_DILIGENCE (7)
| $18,825.10
| $64,075.43
| $12,808.54
| -$9,412.29 (14)
| 8 - STEVE LOKNESS (10)
| -$4,116.52
| $695.09
| $1,446.18 (13)
| 8 - JACK HARTMANN (9)
| $16,971.45
| $65,929.08
| $10,954.89
| -$969.28 (3)
| Top Portfolios’ Contents
| Top Recent Performance Portfolio (KATHLEEN)
| Top YTD Performance Portfolio (BLADERUNNER)
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| CNSP
| 10.00%
| 2.7% | -71.9%
| -$7,194.49
| -$579.53
| 35.6%
| BCAB
| 10.00%
| 5.4% | -0.8%
| -$81.30
| -$1,341.46
| 10.1%
| CRVS
| 10.00%
| 10.5% | 8.0%
| $795.45
| -$1,250.00
| 9.3%
| CRDF
| 20.00%
| 37.2% | 239.9%
| $47,972.97
| $12,027.03
| 1.5%
| ITRM
| 10.00%
| 7.2% | -25.9%
| -$2,588.83
| -$456.85
| 13.5%
| CRIS
| 10.00%
| 4.4% | -19.2%
| -$1,921.57
| -$156.86
| 12.4%
| LXRX
| 10.00%
| 16.5% | 69.9%
| $6,993.46
| $2,810.46
| 5.9%
| GLYC
| 10.00%
| 5.9% | 8.5%
| $847.46
| -$720.34
| 9.2%
| ONVO
| 10.00%
| 9.2% | -5.4%
| -$540.54
| $270.27
| 10.6%
| IMMP
| 10.00%
| 5.4% | -0.4%
| -$41.67
| -$1,500.00
| 10.0%
| PSTV
| 10.00%
| 9.6% | -1.1%
| -$114.29
| $228.57
| 10.1%
| IOVA
| 20.00%
| 18.7% | 71.1%
| $14,218.94
| -$4,403.44
| 2.9%
| SCYX
| 10.00%
| 6.3% | -35.0%
| -$3,497.76
| -$941.70
| 15.4%
| JSPR
| 10.00%
| 17.4% | 217.9%
| $21,787.07
| -$3,130.54
| 3.1%
| SLDB
| 10.00%
| 20.7% | 113.0%
| $11,302.93
| $3,159.61
| 4.7%
| REPL
| 10.00%
| 5.5% | 1.2%
| $118.62
| -$593.12
| 9.9%
| VERU
| 10.00%
| 7.8% | -19.4%
| -$1,944.44
| -$937.50
| 12.4%
|
|
|
|
|
|
| VERV
| 10.00%
| 9.6% | -0.9%
| -$93.26
| -$824.96
| 10.1%
|
|
|
|
|
|
|
|
